Surge in Biotech Valuations: A Tailwind for Life Science Real Estate
Biotech stocks are moving higher and have been since the back end of 2025. The S&P Biotech Index is up 80% year-over-year, with the June rally pushing into the territory of 2021 highs. More M&A in Biotech, stronger . . .
